SPI Pharma has expanded its line of Mannogem Mannitol products for use in multiple patient-friendly oral dosage forms to now include: Man-nogem XL Opal ...
Noramco and SPI Pharma announced they have completed work on an excipient compatibility study examining a range of options for the development of cannabidiol (CBD) solid oral dosage forms ...